冠心病康复治疗中增强型体外反搏的应用及对患者活动耐量与QOL评分的影响

赵云 刘瑾

【摘要】 目的：探究冠心病康復治疗中增强型体外反搏的应用及对患者活动耐量与生活质量（QOL）评分的影响。方法：选取2018年12月-2020年6月本院收治的92例冠心病患者，按随机数字表法分为对照组与研究组，每组46例。对照组采用常规药物治疗，研究组在对照组基础上采用增强型体外反搏治疗。比较两组临床治疗效果、血管不良事件发生情况、治疗前后心功能分级、活动耐量及QOL评分。结果：研究组治疗总有效率高于对照组（P<0.05）;治疗后，研究组心功能Ⅲ级占比低于对照组（P<0.05）;研究组血管不良事件发生率低于对照组（P<0.05）;治疗后，研究组活动耐量及QOL评分均高于对照组（P<0.05）。结论：冠心病患者康复治疗期间应用增强型体外反搏的辅助治疗可以改善患者的心功能，降低并发症发生率，保障患者在康复治疗期间的安全性，提高活动耐量和QOL评分，促使冠心病患者的临床治疗效果趋向于理想化，值得推广应用。

【关键词】 冠心病 康复治疗 增强型体外反搏 活动耐量 QOL评分

[Abstract] Objective： To explore the application of enhanced external counterpulsation in the rehabilitation treatment of coronary heart disease and its influence on activity tolerance and quality of life （QOL） score. Method： A total of 92 patients with coronary heart disease admitted to our hospital from December 2018 to June 2020 were selected. They were divided into control group and study group according to random number table method， 46 patients in each group. The control group was treated with conventional drugs， and the study group was treated with enhanced external counterpulsation on the basis of the control group. Clinical treatment effect， occurrence of vascular adverse events， cardiac function grade， activity tolerance and QOL score before and after treatment were compared between two groups. Result： The total effective rate of the study group was higher than that of the control group （P<0.05）. After treatment， the proportion of class Ⅲ cardiac function in the study group was lower than that in the control group （P<0.05）. The incidence of vascular adverse events in the study group was lower than that in the control group （P<0.05）. After treatment， the activity tolerance and QOL scores of the study group were higher than those of the control group （P<0.05）. Conclusion： The application of enhanced extracorporeal counterpulsation as adjuvant therapy in the rehabilitation treatment of patients with coronary heart disease can improve the cardiac function of patients， reduce the incidence of complications， ensure the safety of patients during rehabilitation treatment， improve activity tolerance and QOL score， and promote the clinical treatment effect of patients with coronary heart disease tends to be ideal， which is worthy of promotion and application.

[Key words] Coronary heart disease Rehabilitation treatment Enhanced external counterpulsation Activity tolerance QOL score

First-authors address： Hongqi Hospital Affiliated to Mudanjiang Medical University， Mudanjiang 157011， China

doi：10.3969/j.issn.1674-4985.2021.09.031

冠心病属于一种临床上普遍存在的心血管疾病，该疾病是因机体内的冠状动脉出现动脉粥样硬化病变而产生血管腔狭窄或阻塞情况，进而引发心肌缺血、缺氧和坏死等严重后果造成的[1]。疾病发生后患者主要表现为心前区疼痛症状，随着病情的持续性发展对患者的心功能产生极大的损害，严重者则会出现死亡等后果。患者在及时有效治疗的同时接受合理化的康复治疗成为持续性优化临床治疗效果、促进患者康复的关键[2-3]。增强型体外反搏（EECP）作为一种新型无创性辅助治疗通过增强内皮血流切应力、降低内皮炎性反应和改善冠状动脉侧支循环情况等效果进一步增强患者的心脏功能，康复效果理想[4-5]。本研究分析了冠心病康复治疗中增强型体外反搏的应用及对患者活动耐量与生活质量（QOL）评分的影响，现报道如下。

1 资料与方法

1.1 一般资料 选取2018年12月-2020年6月本院收治的92例冠心病患者。……